Upgrade to SI Premium - Free Trial

Omeros (OMER)

16.86 +0.60 (3.69%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Omeros shares slide following European regulatory setback for Narsoplimab October 16, 2026 8:10 AM - StreetInsider Omeros narsoplimab receives second negative EU opinion October 16, 2026 6:20 AM - StreetInsider Omeros Corporation Receives CHMP Negative Opinion Following Re-Examination of European Marketing Authorization Application for Narsoplimab in TA-TMA October 16, 2026 6:20 AM - BizWire Omeros (OMER) Reiterated at Overweight by Cantor Fitzgerald Ahead of Potential Catalyst October 14, 2026 7:16 AM - StreetInsider Form 4 OMEROS CORP For: Sep 22 Filed by: Borges David J. September 28, 2026 11:50 AM - SEC Filing Form 4 OMEROS CORP For: Sep 22 Filed by: Borges David J. September 24, 2026 9:01 PM - SEC Filing Form 144 OMEROS CORP Filed by: Borges David J. September 23, 2026 4:21 PM - SEC Filing Form 144 OMEROS CORP Filed by: Borges David J. September 22, 2026 4:15 PM - SEC Filing Cantor Fitzgerald Upgrades Omeros Corp. (OMER) to Overweight, 'We May Have Underestimated Yartemlea' September 22, 2026 6:03 AM - StreetInsider Form 144 OMEROS CORP Filed by: Cancelmo Peter B August 28, 2026 4:35 PM - SEC Filing Form 4 OMEROS CORP For: Aug 26 Filed by: HANISH ARNOLD C August 28, 2026 4:32 PM - SEC Filing Form 144 OMEROS CORP Filed by: HANISH ARNOLD C August 27, 2026 4:13 PM - SEC Filing Form 144 OMEROS CORP Filed by: HANISH ARNOLD C August 26, 2026 4:17 PM - SEC Filing Form 4 OMEROS CORP For: Aug 21 Filed by: Borges David J. August 25, 2026 5:40 PM - SEC Filing Form 4 OMEROS CORP For: Aug 20 Filed by: Cable Thomas J. August 21, 2026 5:34 PM - SEC Filing Form 144 OMEROS CORP Filed by: Borges David J. August 21, 2026 4:42 PM - SEC Filing Form 144 OMEROS CORP Filed by: Cable Thomas J. August 20, 2026 4:24 PM - SEC Filing Form 4 OMEROS CORP For: Aug 12 Filed by: Schocken Joseph L August 18, 2026 9:51 PM - SEC Filing Form 3 OMEROS CORP For: Aug 12 Filed by: Schocken Joseph L August 18, 2026 9:45 PM - SEC Filing Form 4 OMEROS CORP For: Aug 13 Filed by: Borges David J. August 17, 2026 7:43 PM - SEC Filing Form 144 OMEROS CORP Filed by: Borges David J. August 13, 2026 4:37 PM - SEC Filing Form S-8 OMEROS CORP August 13, 2026 4:09 PM - SEC Filing Form 8-K OMEROS CORP For: Aug 12 August 13, 2026 4:07 PM - SEC Filing Form 10-Q OMEROS CORP For: Jun 30 August 12, 2026 4:13 PM - SEC Filing Form 8-K OMEROS CORP For: Aug 12 August 12, 2026 4:10 PM - SEC Filing Omeros (OMER) Tops Q2 EPS by 27c August 12, 2026 4:07 PM - StreetInsider Omeros Corporation Reports Second Quarter 2026 Financial Results August 12, 2026 4:02 PM - BizWire Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026 August 10, 2026 8:00 AM - BizWire CMS grants Medicare add-on payment status to Omeros's TA-TMA drug August 3, 2026 8:32 AM - StreetInsider CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA® August 3, 2026 8:30 AM - BizWire Form SCHEDULE 13G/A OMEROS CORP Filed by: BlackRock, Inc. July 29, 2026 3:23 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Omeros Corp. (OMER) July 28, 2026 6:44 AM - StreetInsider Form 4 OMEROS CORP For: Jul 22 Filed by: Demopulos Gregory A MD July 24, 2026 9:18 PM - SEC Filing Form 4 OMEROS CORP For: Jul 22 Filed by: Cancelmo Peter B July 24, 2026 9:14 PM - SEC Filing Form 4 OMEROS CORP For: Jul 22 Filed by: Borges David J. July 24, 2026 9:12 PM - SEC Filing Full Article List